ReviewBiology2025
Glycosylation and Acylation: Important Regulators of Immune Cell Fate Decisions.
Review in Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Protein Posttranslational Modifications in Immunity: Molecular Mechanisms and Therapeutic Targets.MedComm · 2026Review
- Post-Translational Regulation of CD8Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Review
- Post-translational modifications in CD8Frontiers in immunology · 2026Review
- The Dysregulation of Lysine Acetylation in Esophageal Squamous Cell Carcinoma: Mechanisms, Therapeutic Targets and Clinical Perspectives.Technology in cancer research & treatmentReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Dissecting the determinants of immune cell fate is a central challenge in immunology and is important for understanding cell differentiation, disease diagnosis, and therapy. Post-translational modifications (PTMs) of proteins are chemical modifications of amino acids involving the addition or removal of specific groups. As molecular gatekeepers of immune cell fate, PTMs affect immune function mainly through the regulation of important life processes such as immune cell growth, proliferation, differentiation, activation, and apoptosis. Among PTMs, glycosylation and acylation have emerged as critical regulatory mechanisms governing immune homeostasis. Through precise structural alterations of immune-related proteins and receptors, glycosylation shapes antigen recognition, cytokine signaling, and intercellular communication, while acylation regulates signal transduction and epigenetic modifications in both innate and adaptive immunity. These modifications are involved in the regulation of a wide range of biological processes and are intricately associated with the pathogenesis of many diseases, especially immune diseases. Therefore, this paper reviews the functions and mechanisms of glycosylation and acylation in regulating innate and acquired immunity, to provide new insights into the role of PTMs in disease pathogenesis and potential targeted therapies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.